Dose determination of haloperidol, risperidone and olanzapine using an in vivo dopamine D-2-receptor occupancy method in the rat


Autoria(s): Naiker, D. V.; Catts, S. V.; Catts, V. S.; Bedi, K. S.; Bryan-Lluka, L. J.
Contribuinte(s)

Nijkamp, F. P.

Gispe, W. H.

Data(s)

01/01/2006

Resumo

The purpose of the present study was to determine antipsychotic doses that achieve 80% striatal doparnine D-2-receptor occupancy for haloperidol, risperidone and olanzapine in rats. Wistar rats were treated with normal saline vehicle (controls), haloperidol (0.25 and 0.5 mg/kg/ day), risperidone (3, 5 and 6 mg/kg/day) and olanzapine (5 and 10 mg/kg/day) for 7 days via osmotic minipumps. Striatal and cerebellar tissue were collected and in vivo dopamine D2-receptor occupancies were determined using H-3-raclopride. The doses required to achieve dopamine D-2-receptor occupancy of 80% in 11- and 24-week old rats were: haloperidol 0.25 mg/kg/day, risperidone 5 mg/kg/day and olanzapine 10 mg/kg/day. (c) 2006 Elsevier B.V All rights reserved.

Identificador

http://espace.library.uq.edu.au/view/UQ:79242

Idioma(s)

eng

Publicador

Elsevier BV

Palavras-Chave #Pharmacology & Pharmacy #Dopamine D-2-receptor Occupancy #In Vivo #Raclopride #Dosage #Olanzapine #Risperidone #Positron Emission Tomography #Receptor Occupancy #Human-brain #Atypical Antipsychotics #Binding #Pet #H-3-raclopride #Ligands #Drugs #C1 #270502 Neurobiology #780105 Biological sciences
Tipo

Journal Article